CXCL8 and breast cancer: While it may not substantially alter the proliferative ability of mammary carcinoma cells, CXCL8 heightens the invasiveness and miration of both murine and human breast tumors, triggers epithelial–mesenchymal transition (EMT), and supports the self-renewal capacity of BC stem cells (BCSCs) (49).